Autoimmunity in Women: Mechanisms and Emerging Therapies
Women account for nearly 80% of autoimmune disease cases in the United States, yet the biological reasons behind this disparity have only recently come into focus. Join us for a conversation at the frontier of one of medicine’s most important emerging questions: why are women so much more vulnerable to autoimmune disease, and what are we going to do about it?
This panel brings together a researcher whose work is rewriting our understanding of the X chromosome’s role in immunity, a precision medicine entrepreneur deploying AI to predict and prevent lupus flares, and a pharmaceutical executive translating the latest science into therapies reaching patients today. Together, they will explore the mechanisms driving sex-biased autoimmunity, the diagnostic and therapeutic tools now entering the clinic, and where the next decade of innovation is headed.
Speakers
Tiffany Keaton – Session Moderator
Founder
Avinity Advisors
Diane Ammerman
Regional Medical Science Liaison Director Neurology
Genentech
Diana Dou
Assistant Professor
Duke University School of Medicine
Amrie Grammer
Founder and CEO
AMPel BioSolutions